Literature DB >> 29686039

Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Viet Loan Dao Thi1, Xianfang Wu1, Charles M Rice1.   

Abstract

Similar to other hepatotropic viruses, hepatitis E virus (HEV) has been notoriously difficult to propagate in cell culture, limiting studies to unravel its biology. Recently, major advances have been made by passaging primary HEV isolates and selecting variants that replicate efficiently in carcinoma cells. These adaptations, however, can alter HEV biology. We have explored human embryonic or induced pluripotent stem cell (hESC/iPSC)-derived hepatocyte-like cells (HLCs) as an alternative to conventional hepatoma and hepatocyte cell culture systems for HEV studies. HLCs are permissive for nonadapted HEV isolate genotypes (gt)1-4 replication and can be readily genetically manipulated. HLCs, therefore, enable studies of pan-genotype HEV biology and will serve as a platform for testing anti-HEV treatments. Finally, we discuss how hepatocyte polarity is likely an important factor in the maturation and spread of infectious HEV particles.
Copyright © 2019 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 29686039      PMCID: PMC6396339          DOI: 10.1101/cshperspect.a031799

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  110 in total

1.  Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms.

Authors:  Purnima Bhat; Michelle J Snooks; David A Anderson
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Naked Viruses That Aren't Always Naked: Quasi-Enveloped Agents of Acute Hepatitis.

Authors:  Zongdi Feng; Asuka Hirai-Yuki; Kevin L McKnight; Stanley M Lemon
Journal:  Annu Rev Virol       Date:  2014-07-03       Impact factor: 10.431

3.  The 3' end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp).

Authors:  S Agrawal; D Gupta; S K Panda
Journal:  Virology       Date:  2001-03-30       Impact factor: 3.616

4.  Apolipoprotein E and protection against hepatitis E viral infection in American non-Hispanic blacks.

Authors:  Lyna Zhang; Ajay Yesupriya; Man-Huei Chang; Eyasu Teshale; Chong-Gee Teo
Journal:  Hepatology       Date:  2015-07-28       Impact factor: 17.425

5.  Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.

Authors:  Yijin Wang; Xinying Zhou; Yannick Debing; Kan Chen; Luc J W Van Der Laan; Johan Neyts; Harry L A Janssen; Herold J Metselaar; Maikel P Peppelenbosch; Qiuwei Pan
Journal:  Gastroenterology       Date:  2014-02-26       Impact factor: 22.682

6.  Replacement of the hepatitis E virus ORF3 protein PxxP motif with heterologous late domain motifs affects virus release via interaction with TSG101.

Authors:  Scott P Kenney; Jacquelyn L Wentworth; Connie L Heffron; Xiang-Jin Meng
Journal:  Virology       Date:  2015-10-27       Impact factor: 3.616

7.  Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.

Authors:  Ibrahim M Sayed; Lieven Verhoye; Laurence Cocquerel; Florence Abravanel; Lander Foquet; Claire Montpellier; Yannick Debing; Ali Farhoudi; Czeslaw Wychowski; Jean Dubuisson; Geert Leroux-Roels; Johan Neyts; Jacques Izopet; Thomas Michiels; Philip Meuleman
Journal:  Gut       Date:  2016-03-22       Impact factor: 23.059

8.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  The Hepatitis E virus intraviral interactome.

Authors:  Andreas Osterman; Thorsten Stellberger; Anna Gebhardt; Marisa Kurz; Caroline C Friedel; Peter Uetz; Hans Nitschko; Armin Baiker; Maria G Vizoso-Pinto
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

10.  Biliary Secretion of Quasi-Enveloped Human Hepatitis A Virus.

Authors:  Asuka Hirai-Yuki; Lucinda Hensley; Jason K Whitmire; Stanley M Lemon
Journal:  mBio       Date:  2016-12-06       Impact factor: 7.867

View more
  8 in total

Review 1.  Hepatitis A Virus and Hepatitis E Virus: Emerging and Re-Emerging Enterically Transmitted Hepatitis Viruses.

Authors:  Stanley M Lemon; Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-06-03       Impact factor: 6.915

Review 2.  Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells.

Authors:  Josef Blaszkiewicz; Stephen A Duncan
Journal:  Genes (Basel)       Date:  2022-03-24       Impact factor: 4.141

Review 3.  Life cycle and morphogenesis of the hepatitis E virus.

Authors:  Kiyoshi Himmelsbach; Daniela Bender; Eberhard Hildt
Journal:  Emerg Microbes Infect       Date:  2018-11-29       Impact factor: 7.163

Review 4.  Cell Culture Models for Hepatitis E Virus.

Authors:  Rebecca Menhua Fu; Charlotte Caroline Decker; Viet Loan Dao Thi
Journal:  Viruses       Date:  2019-07-03       Impact factor: 5.048

Review 5.  Animal Models for Hepatitis E virus.

Authors:  Laura Corneillie; Dominic H Banda; Philip Meuleman
Journal:  Viruses       Date:  2019-06-18       Impact factor: 5.048

Review 6.  Virus-Host Cell Interplay during Hepatitis E Virus Infection.

Authors:  Michael H Wißing; Yannick Brüggemann; Eike Steinmann; Daniel Todt
Journal:  Trends Microbiol       Date:  2020-08-19       Impact factor: 18.230

7.  Robust hepatitis E virus infection and transcriptional response in human hepatocytes.

Authors:  Daniel Todt; Martina Friesland; Nora Moeller; Dimas Praditya; Volker Kinast; Yannick Brüggemann; Leonard Knegendorf; Thomas Burkard; Joerg Steinmann; Rani Burm; Lieven Verhoye; Avista Wahid; Toni Luise Meister; Michael Engelmann; Vanessa M Pfankuche; Christina Puff; Florian W R Vondran; Wolfgang Baumgärtner; Philip Meuleman; Patrick Behrendt; Eike Steinmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-02       Impact factor: 11.205

Review 8.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.